Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence

Abstract Background In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevention, was low (~ 34%), yet self-reported adherence...

Full description

Bibliographic Details
Main Authors: Ariana W. K. Katz, Barbara S. Mensch, Kubashni Woeber, Petina Musara, Juliane Etima, Ariane van der Straten
Format: Article
Published: BMC 2019-01-01
Series:BMC Women's Health
Online Access:http://link.springer.com/article/10.1186/s12905-019-0713-6